Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.
about
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceOspemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.Pharmacology and clinical applications of selective estrogen receptor modulators.Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopauseOspemifene use in postmenopausal women.Designing the ideal selective estrogen receptor modulator--an achievable goal?SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.Effects of ospemifene on drug metabolism mediated by cytochrome P450 enzymes in humans in vitro and in vivo.Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast.Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.Pharmacologic evaluation of ospemifene.Ospemifene: first global approval.Treatment of vaginal atrophy.Pharmacokinetics, pharmacodynamics and clinical efficacy of ospemifene for the treatment of dyspareunia and genitourinary syndrome of menopause.Progress and prospects in treating postmenopausal vaginal atrophy.Effect of toremifene and ospemifene, compared to acolbifene, on estrogen-sensitive parameters in rat and human uterine tissues.Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy.Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.Pharmacologic effects of ospemifene in rhesus macaques: a pilot study.Effects of ospemifene on vaginal epithelium of post-menopausal women.Ospemifene: a novel selective estrogen receptor modulator for treatment of dyspareunia.
P2860
Q25257848-75304B52-DBED-47D9-9FE6-F681CCEAA887Q26830744-769675A6-F43D-4FF0-8F11-DCD2AC688039Q30491704-A5165656-FB97-458D-9372-4EF42D26A491Q33384192-B5C42D72-C37B-4811-8858-574F6C8DFD7BQ34532021-C5098467-FBB0-445F-84F2-8700447CA86CQ34982860-3DD656CB-E56A-4E33-8871-ED64CF0DCB63Q35023776-C2FD748E-4DFE-4E7B-A0E0-793C904237B6Q35028647-4F22673A-7F32-460E-BE15-E953BD248E8DQ35634204-9D858F80-441B-43F7-A1AA-6C837844CFDFQ35824414-197EF7F7-BC0F-4A5C-8EF2-6228EF642AE0Q36219667-74D561EA-CDEF-46E4-A9F8-07B9E9B8BA54Q36927087-3DE117DD-5E5A-4F26-A2EF-FB4D27E00979Q37091899-3FF922EE-BCBA-4112-A97F-14D532C795F8Q37156496-EBF0FA9E-7ECE-4EB7-B85C-B9D04F364CCFQ37221035-E8FF759A-652A-4F12-8EF2-8BC2B88205DBQ37677579-C1E4D723-08EB-4A78-BDC9-DF1C929FD252Q37739433-23FC9CC8-B35F-45CC-9308-D2BDA7AF22C1Q38100714-8028388A-E35C-492A-A934-D7ED08909C26Q38193877-9FFC3A19-DA7C-4600-8865-F4892824B54BQ38836000-7783E3E8-D464-45E2-9E5F-555027462100Q39827992-60ECC14A-4167-4D02-87D7-F347FFD0DA42Q40953602-B1E2E6A7-8D2A-4A62-9767-546697D51A19Q41689276-A59C3EC8-4ABD-4DB3-9A6C-20C254F23F23Q45070875-09CFE978-3EB2-4935-93E8-D1364772F561Q46530065-9E5615EC-94D9-451C-AC5F-A894FA8724B7Q50611000-E0D3B877-CA16-40D9-BF42-D7184701A5DFQ51105627-2C613FE5-96FC-4293-B12C-8C3ABC234960
P2860
Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@ast
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@en
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@nl
type
label
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@ast
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@en
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@nl
prefLabel
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@ast
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@en
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@nl
P2093
P1433
P1476
Effects of ospemifene, a novel ...... ouble-blind, randomized trial.
@en
P2093
Eeva-Marja Rutanen
Janne Komi
Jorma Heikkinen
Kaija Halonen
Risto Lammintausta
P304
P356
10.1097/01.GME.0000063609.62485.27
P407
P577
2003-09-01T00:00:00Z